A, percentage recovery in islets treated with 100 μm
18-α-glycyrrhetinic acid (α-GA) or 100 μm mebeverine (Meb) normalized
to untreated Cx36+/+ islets. Data represent the mean ±
s.e.m. over three mice, with each data point averaged over one to three islets per mouse.
B, recovery rate in Cx36+/+ islets either untreated or
treated with 50 μm modafinil for 1 h, normalized to untreated islets. Data represent
the mean ± s.e.m. over three mice, with each data point averaged over one to three
islets per mouse. C, percentage recovery in Cx36+/+ and
Cx36−/− islets either untreated or treated with 100 μm
3-isobutyl-1-methylxanthine (IBMX) with 50 μm forskolin (F + IBMX) normalized
to untreated Cx36+/+ islets. Data represent the mean ±
s.e.m. over three or four mice, with each data point averaged over three or four islets per
mouse. For Cx36−/− islets, the mean and s.d. are also presented
above the respective data columns. D, recovery rate in C57BL/6 islets cultured in 2
mm, 5 mm or 11 mm glucose for 1 h or 20 mm glucose for 10 min,
normalized to recovery rate at 2 mm glucose. Data represent the mean ±
s.e.m. over three mice, with each data point averaged over two or three islets per mouse.
E, recovery rate in C57BL/6 islets cultured in 2 mm, 5 mm, 11
mm or 20 mm glucose for 24 h, normalized to recovery rate at 2 mm
glucose. Data represent the mean ± s.e.m. over three mice, with each data point
averaged over two to three islets per mouse. *P < 0.001. NS, no
significant difference between conditions.